These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38510786)

  • 1. The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and Outpatients.
    Chang HY; Wang SH; Kuo HT; Sheu MJ; Feng IC; Ho CH; Chen JY; Sun CS; Chen CH; Lin CY; Yang CC
    Int J Hepatol; 2024; 2024():3184892. PubMed ID: 38510786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.
    Dhiman RK; Grover GS; Premkumar M; Roy A; Taneja S; Duseja A; Arora S;
    EClinicalMedicine; 2021 Nov; 41():101148. PubMed ID: 34712928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment.
    Cheng TS; Liang PC; Huang CF; Yeh ML; Huang CI; Lin ZY; Chen SC; Huang JF; Dai CY; Hsieh PH; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2021 Apr; 37(4):334-345. PubMed ID: 33151016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland.
    Bachofner J; Valli PV; Bergamin I; Kröger A; Künzler P; Baserga A; Braun DL; Seifert B; Moncsek A; Fehr J; Semela D; Magenta L; Müllhaupt B; Terziroli Beretta-Piccoli B; Mertens J; The Swiss Hepatitis C Cohort Study
    Swiss Med Wkly; 2018; 148():w14560. PubMed ID: 29376557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan.
    Yang TH; Fang YJ; Hsu SJ; Lee JY; Chiu MC; Yu JJ; Kuo CC; Chen CH
    Open Forum Infect Dis; 2020 Aug; 7(8):ofaa301. PubMed ID: 32818142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients.
    Wong YJ; Thurairajah PH; Kumar R; Fock KM; Law NM; Chong SY; Manejero FG; Ang TL; Teo EK; Tan J
    Clin Mol Hepatol; 2021 Jul; 27(3):474-485. PubMed ID: 33601868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up of sustained virological response with hepatitis C infection after direct-acting antiviral therapy: A single-center retrospective study.
    Li M; Li Y; Zhang Y; Wang X; Lin C
    Medicine (Baltimore); 2024 Feb; 103(7):e37212. PubMed ID: 38363923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting.
    Gayam V; Mandal AK; Khalid M; Mukhtar O; Gill A; Garlapati P; Khalid M; Mansour M
    Int J Hepatol; 2018; 2018():4136253. PubMed ID: 30155312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hepatitis C virus treatment between incarcerated and community patients.
    Rice JP; Burnett D; Tsotsis H; Lindstrom MJ; Cornett DD; Voermans P; Sawyer J; Striker R; Lucey MR
    Hepatology; 2012 Oct; 56(4):1252-60. PubMed ID: 22505121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sofosbuvir and Velpatasvir Regimen Outcome for Chronic Hepatitis C Patients With End-Stage Renal Disease Undergoing Hemodialysis.
    Shahid S; Asghar S; Mahmood T; Fatima M; Rasheed A; Asghar S
    Cureus; 2023 Sep; 15(9):e45680. PubMed ID: 37868481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals.
    Hsu CE; Liu YC; Cheng YT; Jeng WJ; Chien RN; Lin CY; Tai DI; Sheen IS
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment.
    Niu B; Zang W; Zhou H; Mi Y; Lu C; Li P
    BMC Gastroenterol; 2023 Apr; 23(1):102. PubMed ID: 37013471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of factors affecting response of direct-acting antivirals in chronic hepatitis C patients.
    Jain N; Garg R; Singh GP; Kaur S; Chawla SPS; Padda P
    Ann Afr Med; 2023; 22(4):456-464. PubMed ID: 38358146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
    Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
    J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of chronic hepatitis C genotype and evaluation of clinical factors affecting direct-acting antiviral treatment responses in the Western Black Sea Region, Turkey.
    Gok Sargin Z; Dusunceli I
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7256-7262. PubMed ID: 36263536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.
    Chen G; Wang C; Chen J; Ji D; Wang Y; Wu V; Karlberg J; Lau G
    Hepatology; 2017 Jul; 66(1):13-26. PubMed ID: 28195337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-acting antivirals for chronic hepatitis C.
    Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012143. PubMed ID: 28922704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit.
    Lions C; Laroche H; Zaegel-Faucher O; Ressiot E; Bregigeon S; Geneau de Lamarliere P; Solas C; Tamalet C; Pieve MA; Ritleng AS; Debreux C; Ivanova A; Obry-Roguet V; Carrieri P; Poizot-Martin I
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1212-1221. PubMed ID: 31851097
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.